TABLE 5.
Logistic regression analyses for the association between non-insulin-based IR indices and a CAVI ≥ 8.0.
Variables | OR (95%CI) for CAVI ≥ 8.0 |
|
Model 1 | Model 2 | |
TG/HDL-C | ||
Q1 | Reference | Reference |
Q2 | 2.151 (1.478–3.130)** | 1.770 (1.092–2.869)* |
Q3 | 1.778 (1.209–2.615)* | 1.217 (0.742–1.995) |
Q4 | 2.824 (1.964–4.060)** | 2.434 (1.491–3.975)** |
TyG | ||
Q1 | Reference | Reference |
Q2 | 1.933 (1.274–2.934) * | 1.467 (0.874–2.461) |
Q3 | 2.768 (1.859–4.123) ** | 1.818 (1.098–3.009)* |
Q4 | 3.962 (2.698–5.818) ** | 2.346 (1.413–3.896)** |
METS-IR | ||
Q1 | Reference | Reference |
Q2 | 1.433 (0.986–2.083) | 1.571 (0.923–2.674) |
Q3 | 2.023 (1.420–2.883)** | 1.831(0.998–3.358) |
Q4 | 2.146 (1.510–3.049)** | 2.699 (1.235–5.897) * |
TG, triglyceride; HDL-C, high density lipoprotein cholesterol; TyG, triglyceride and glucose index; METS-IR, metabolic score for insulin resistance; CAVI, cardio-ankle vascular index; CI, confidence interval.
Model 1: unadjusted.
Model 2: adjusted for age, sex, BMI, smoking, drinking, prehypertension, diabetes mellitus, hyperuricemia, renal dysfunction, SBP, and DBP.
*p < 0.05; **P < 0.001.